Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LRRK2”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableStudy completedNCT01085227
What this trial is testing

Clinical, Molecular and by Neuroimaging of LRRK2 Mutations

Who this might be right for
Parkinson's Disease
Institut National de la Santé Et de la Recherche Médicale, France 50
Not applicableEnded earlyNCT05349019
What this trial is testing

A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease

Who this might be right for
Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene
Escape Bio, Inc. 22
Not applicableStudy completedNCT01536821
What this trial is testing

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

Who this might be right for
Parkinson Disease
Indiana University 81
Not applicableUnknownNCT04387812
What this trial is testing

Evaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's Disease

Who this might be right for
Parkinson DiseaseGBA Gene MutationLeucine-rich Repeat Kinase 2 (LRRK2) Gene Mutation
Tel-Aviv Sourasky Medical Center 240
Not applicableStudy completedNCT03545425
What this trial is testing

Fox BioNet Project: LRRK2-002

Who this might be right for
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research 114
Testing effectiveness (Phase 2)Looking for participantsNCT07020026
What this trial is testing

Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease

Who this might be right for
Parkinson's Disease
Michael J. Fox Foundation for Parkinson's Research 60
Not applicableEnded earlyNCT04919356
What this trial is testing

Parkinson's Disease G2019S LRRK2 Genetic Testing Program

Who this might be right for
Parkinson's Disease
Escape Bio, Inc. 836
Not applicableStudy completedNCT04668898
What this trial is testing

LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease

Who this might be right for
Parkinson DiseaseLRRK2GBA Gene Mutation
Icahn School of Medicine at Mount Sinai 203
Not applicableEnded earlyNCT01618383
What this trial is testing

Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation

Who this might be right for
Parkinson's Disease
Nantes University Hospital 19
Not applicableNot Yet RecruitingNCT06993142
What this trial is testing

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more
Radboud University Medical Center 600
Not applicableUnknownNCT04436848
What this trial is testing

LRRK2 G2385R Leucocyte and Urine Biomarker Study

Who this might be right for
Parkinson Disease
University of Malaya 150
Not applicableStudy completedNCT03866603
What this trial is testing

Rostock International Parkinson's Disease Study (ROPAD)

Who this might be right for
Parkinson´s Disease
CENTOGENE GmbH Rostock 20,112
Not applicableStudy completedNCT05287620
What this trial is testing

Objective, Passive Assessment of LRRK2 Carriers

Who this might be right for
Parkinson Disease
University of Rochester 10
Not applicableUnknownNCT04214509
What this trial is testing

LIPAD - LRRK2 International Parkinson's Disease Study

Who this might be right for
Parkinson's Disease and Parkinsonism
University of Luebeck 4,000
Not applicableEnded earlyNCT00467090
What this trial is testing

Characteristics of Parkinson s Disease Associated With the LRRK-2 Gene Mutation

Who this might be right for
Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 34
Post-approval studies (Phase 4)UnknownNCT05355064
What this trial is testing

Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease

Who this might be right for
Parkinson Disease
Neuromed IRCCS 20
Not applicableStudy completedNCT04349865
What this trial is testing

LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers

Who this might be right for
Parkinson Disease
Xuanwu Hospital, Beijing 211
Very early researchStudy completedNCT05837130
What this trial is testing

Non-drug Treatment Study in Parkinson's Disease Patients and Healthy Volunteers to Collect Biological Samples in Order to Assess ex Vivo the Activity of Candidate Therapies and Develop Novel Analytical Methods for Biomarkers

Who this might be right for
Parkinson Disease
Servier 45
Not applicableStudy completedNCT03782753
What this trial is testing

Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's Disease

Who this might be right for
Parkinson Disease, PARK8Parkinson DiseaseIdiopathic Parkinson Disease
King's College London 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT06602193
What this trial is testing

Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)

Who this might be right for
Parkinson Disease
Denali Therapeutics Inc. 50
Load More Results